ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $290,000 | +37.4% | 1,683 | 0.0% | 0.00% | – |
Q2 2021 | $211,000 | -7.5% | 1,683 | 0.0% | 0.00% | – |
Q1 2021 | $228,000 | -17.1% | 1,683 | -21.8% | 0.00% | – |
Q4 2020 | $275,000 | +95.0% | 2,151 | +71.9% | 0.00% | – |
Q3 2020 | $141,000 | -17.1% | 1,251 | -29.9% | 0.00% | – |
Q2 2020 | $170,000 | +102.4% | 1,785 | +91.7% | 0.00% | – |
Q1 2020 | $84,000 | -16.8% | 931 | -51.0% | 0.00% | – |
Q4 2019 | $101,000 | +1583.3% | 1,900 | +1800.0% | 0.00% | – |
Q3 2018 | $6,000 | -84.6% | 100 | -87.5% | 0.00% | – |
Q2 2018 | $39,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |